Morgan Stanley Enovis Corp Transaction History

Morgan Stanley

$1.49 Trillion
Q2 2025

A detailed history of Morgan Stanley transactions in Enovis Corp stock. As of the latest transaction made, Morgan Stanley holds 1,354,755 shares of ENOV stock, worth $43.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,354,755

Previous 1,106,229 22.47%

Holding current value

$43.7 Million

Previous $42.3 Million 0.51%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 15, 2025	BUY	$29.65 - $37.35 $7.37 Million - $9.28 Million	248,526 Added 22.47%	1,354,755 $42.5 Million
Q1 2025 May 15, 2025	BUY	$35.51 - $47.99 $9.78 Million - $13.2 Million	275,420 Added 33.15%	1,106,229 $42.3 Million
Q4 2024 Feb 14, 2025	BUY	$38.5 - $49.33 $895,317 - $1.15 Million	23,255 Added 2.88%	830,809 $36.5 Million
Q3 2024 May 14, 2025	SELL	$40.57 - $48.1 $7.77 Million - $9.22 Million	-191,587 Reduced 19.18%	807,554 $34.8 Million
Q3 2024 Nov 14, 2024	SELL	$40.57 - $48.1 $7.77 Million - $9.22 Million	-191,587 Reduced 19.18%	807,554 $34.8 Million
Q2 2024 May 14, 2025	BUY	$44.56 - $62.43 $7.5 Million - $10.5 Million	168,332 Added 20.26%	999,141 $45.2 Million
Q2 2024 Oct 17, 2024	BUY	$44.56 - $62.43 $3.16 Million - $4.43 Million	70,939 Added 7.64%	999,141 $45.2 Million
Q2 2024 Aug 14, 2024	BUY	$44.56 - $62.43 $3.16 Million - $4.43 Million	70,939 Added 7.64%	999,141 $45.2 Million
Q1 2024 Oct 17, 2024	SELL	$55.44 - $63.8 $3.93 Million - $4.53 Million	-70,939 Reduced 7.1%	928,202 $58 Million
Q1 2024 Aug 16, 2024	BUY	$55.44 - $63.8 $2.38 Million - $2.74 Million	42,962 Added 4.85%	928,202 $58 Million
Q1 2024 May 15, 2024	BUY	$55.44 - $63.8 $2.38 Million - $2.74 Million	42,962 Added 4.85%	928,202 $58 Million
Q4 2023 Aug 16, 2024	SELL	$43.67 - $57.07 $4.97 Million - $6.5 Million	-113,901 Reduced 11.4%	885,240 $49.6 Million
Q4 2023 Feb 13, 2024	BUY	$43.67 - $57.07 $5.31 Million - $6.93 Million	121,510 Added 15.91%	885,240 $49.6 Million
Q3 2023 Nov 15, 2023	BUY	$51.65 - $65.54 $10.9 Million - $13.8 Million	211,142 Added 38.21%	763,730 $40.3 Million
Q2 2023 Aug 14, 2023	BUY	$52.7 - $64.12 $8.5 Million - $10.3 Million	161,319 Added 41.23%	552,588 $35.4 Million
Q1 2023 May 15, 2023	BUY	$49.5 - $65.92 $1.49 Million - $1.98 Million	30,107 Added 8.34%	391,269 $20.9 Million
Q4 2022 Feb 14, 2023	BUY	$44.83 - $57.43 $2.92 Million - $3.74 Million	65,118 Added 22.0%	361,162 $19.3 Million
Q3 2022 Nov 14, 2022	SELL	$46.07 - $60.1 $1.17 Million - $1.52 Million	-25,369 Reduced 7.89%	296,044 $13.6 Million
Q2 2022 Aug 15, 2022	BUY	$55.0 - $70.47 $17.7 Million - $22.6 Million	321,413 New	321,413 $17.7 Million

Others Institutions Holding ENOV

# of Institutions

312

Shares Held

64.9M

Call Options Held

2.02M

Put Options Held

332K

View Full List

About Enovis CORP

Ticker ENOV
Exchange NYSE
Sector Industrials
Industry Specialty Industrial Machinery
Shares Outstandng 54,129,500
Market Cap $1.75B
Description
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...

More about ENOV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account